期刊文献+

一株抗人血小板第4因子单克隆抗体(SZ-95)的特异性鉴定

Study on epitope and function of a novel monoclonal antibody against platelet factor 4
下载PDF
导出
摘要 目的  研究一株新制备的抗人血小板第4因子(PF4)单克隆抗体(mAb)SZ-95的抗原表位和对PF4结合肝素功能的影响。 方法通过间接ELISA、Western blot以及肝素-PF4复合物ELISA研究SZ-95所识别的抗原决定簇和其对PF4生物学功能的影响。 结果 这株特异性识别人PF4的mAb不识别与PF4高度同源的β-血小板球蛋白(β-TG),以及包括PF4分子中部大部分β折叠的合成多肽(P34-58)。并且,抗体结合肝素-PF4复合物的数量随复合物中的肝素量增加而减少。结论我们推测SZ-95识别的抗原表位可能位于人PF4 N末端的可变区域或者C末端α螺旋。并且mAb结合肝素-PF4复合物的肝素剂量依赖性改变,说明SZ-95识别的抗原表位与肝素与PF4的结合位点有关,可能影响PF4中和肝素的功能,有助于PF4结构和功能的进一步研究。 Aim To identify the epitope recognized by a novel monoclonal antibody SZ-95 against Platelet Factor 4(PF4) and to study its effect on PF4 binding to heparin. Methods The epitope of SZ-95 and its action on biological activities of PF4 was determined by indirect ELISA,Western blot and heparin-PF4 complex ELISA.Results The mAb SZ-95 recognizing human PF4 specifically does not react with beta-thromboglobulin(β-TG) and the synthetic peptide corresponding to amino acids 34 to 58 (P34-58). The number of SZ-95 binding to heparin-PF4 complex reduces along with the increment of heparin in complex. Conclusion It is suggested that the epitope of SZ-95 locate in the carboxylterminal α-helix or conformation flexible N-terminal region.The quantity of SZ-95 binding to heparin-PF4 complex dependent on the number of heparin in complex demonstrated that the epitope of SZ-95 is related to the binding site of PF4 on heparin.The effect of SZ-95 on PF4 binding to heparin provides evidence for further study fo structure and function of PF4.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2002年第2期165-167,共3页 Chinese Journal of Cellular and Molecular Immunology
关键词 血小板第4因子 单克隆抗体 Β-血小板球蛋白 肝素 特异性鉴定 Platelet Factor 4 Monoclonal Antibody beta-thromboglobulin Heparin
  • 相关文献

参考文献9

  • 1王振义 李家增 等.血栓与止血-基础理论与临床(第2版)[M].上海:上海科学技术出版社,1995.227-237,615-630.
  • 2Rollins BJ. Chemokine.Blood, 1997, 90:909-911.
  • 3Petersen F, Bock L, Flad HD, et al. Platelet factor 4-induced neutrophil-endothelial cell interaction: involvement of mechanisms and functional consequences different from those elicited by interleukin-8.Blood, 1999, 94:4020-4028.
  • 4Lecomte-Raclet L, Alemany M, Sequira-Le G, et al. New insights into the negative of hematopoiesis by chemokine platelet factor 4 and related peptides.Blood, 1998, 91:2772-2780.
  • 5许卫东,赵益明,李佩霞,沈文红,何杨,阮长耿.脾内免疫制备抗人血小板第4因子单克隆抗体和鉴定[J].中国血液流变学杂志,2001,11(1):18-20. 被引量:4
  • 6Woodhams BJ, Grimaux M. Detection of PF4-heparin auto-antibodies by ELISA.Thromb Haemost, 1999, 82:157-159.
  • 7Brandt E, Petersen F, Ludwig A, et al. The beta-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation.J Leukoc Biol, 2000, 67:471-478.
  • 8Lecomte-Raclet L, Rholam M, Alemany M,et al. Dual structural requirements for multilineage hematopoietic-suppressive activity of chemokine-derived peptides.Biochemistry, 2000,39:9612-9622.
  • 9Mayo KH, Ilyina E, Roongta V, et al. Heparin binding to platelet factor-4: An NMR and site-directed mutagenesis study: arginine residues are crucial for binding. Biochem J, 1995, 312:357-365.

二级参考文献1

  • 1阮长耿 等.抗人血小板单克隆抗体的Ⅰ:一组分泌抗人血小板单克隆抗体的小鼠杂交瘤细胞[J].中华血液学杂志,1985,6:130-130.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部